Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,157,519
-$1,026,604 QoQ
Shares Held
725,061
+12.3% QoQ
Ownership
2.49%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. ENTA ranks #169 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,157,519 | 725,061 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,184,123 | 645,791 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,903,531 | 493,194 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,672,624 | 485,797 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,728,011 | 494,205 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,744,077 | 477,231 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,945,355 | 477,351 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,002,204 | 462,776 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,718,577 | 442,072 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,039,120 | 429,237 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,576,349 | 409,700 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,641,384 | 403,803 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,976,873 | 395,076 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,628,335 | 378,941 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,827,824 | 362,981 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,368,277 | 346,272 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $25,106,324 | 352,716 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,126,678 | 336,008 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $18,962,780 | 333,793 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $14,541,300 | 330,409 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $15,414,670 | 312,544 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $12,022,918 | 285,580 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $12,588,859 | 274,986 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,391,860 | 266,717 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,308,798 | 258,775 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||